Clinical trials in transplantation
Abatacept in Treatment Resistant Nephrotic Syndrome
ASCEND: Trial of prolyl hydroxylase inhibitors in patients with CKD and ESRD
Avacopan in C3GN; MAINTANCAVAS: Maintenance treatment in ANCA vasculitis
Eculizumab for recurrent aHUS post transplant
Novel drug targets and dietary interventions to promote immune regulation in humans
ASCEND Clinical development program – a phase 3 program for the development of a novel propyl hydroxylase inhibitor Daprodustat.
Clinical trials in Hepatitis C virus infection and HCV+ to HCV-naive kidney transplantation